Learn More
Medchemexpress LLC Ftísadtsk-13c 6,15n2(tfa) | 96.04% | 1091.01 | 10 MG

Supplier: Medchemexpress LLC HYP3146S10MG
FTISADTSK-13C6,15N2 TFA is a 13C- and 15N-labeled peptide that serves as an endogenous stable signature peptide from Trastuzumab. It is monitored by selected reaction monitoring (SRM) and utilized as a tracer for quantitation during drug development.
- 13C- and 15N-labeled peptide
- Stable signature peptide from Trastuzumab
- Monitored by selected reaction monitoring (SRM)
- Used as a tracer for quantitation in drug development
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.